Constellium to Appoint Bradley L. Soultz as Special Advisor to the Board of Directors
PARIS, Aug. 27, 2024 (GLOBE NEWSWIRE) — Constellium SE (NYSE: CSTM) today announced that Mr. Bradley L. Soultz will be […]
Flotek to Present at the 2024 Gateway Conference on September 4, 2024
HOUSTON, Texas, Aug. 27, 2024 (GLOBE NEWSWIRE) — Flotek Industries, Inc. (“Flotek”) (NYSE: FTK), an advanced technology-driven, green chemical and […]
Hyliion Holdings to Present at the 2024 Gateway Conference on September 4, 2024
AUSTIN, Texas, Aug. 27, 2024 (GLOBE NEWSWIRE) — Hyliion Holdings Corp. (“Hyliion” or the “Company”) (NYSE: HYLN), a developer of […]
Forum Energy Technologies to Present at the 2024 Gateway Conference on September 4, 2024
HOUSTON, Aug. 27, 2024 (GLOBE NEWSWIRE) — Forum Energy Technologies, Inc. (NYSE: FET) (“FET”), a global designer, manufacturer and distributor […]
BetterLife Highlights Advantages of Non-hallucinogenic LSD Derivative BETR-001 and Publication of its Methods to Treat Mood Disorders Patent
VANCOUVER, British Columbia, Aug. 27, 2024 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF […]
Ressources Cerro de Pasco obtient une autorisation historique et commence à forer les résidus de Quiulacocha
MONTRÉAL, 27 août 2024 (GLOBE NEWSWIRE) — Ressources Cerro de Pasco Inc. (CSE : CDPR) (OTCPK : GPPRF) (FRA : […]
Cerro de Pasco Resources is Granted Historic Authorization and Starts Drilling Quiulacocha Tailings
MONTRÉAL, Aug. 27, 2024 (GLOBE NEWSWIRE) — Cerro de Pasco Resources Inc. (CSE: CDPR) (OTCPK: GPPRF) (FRA: N8HP) (“CDPR” or […]
SCYNEXIS to Participate in H. C. Wainwright 26th Annual Global Investment Conference
JERSEY CITY, N.J., Aug. 27, 2024 (GLOBE NEWSWIRE) — SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to […]
Enphase Energy Begins Pre-Orders for IQ Battery 5Ps Produced in the United States
FREMONT, Calif., Aug. 27, 2024 (GLOBE NEWSWIRE) — Enphase Energy, Inc. (NASDAQ: ENPH), a global energy technology company and the […]
Entourage Health Reports Second Quarter 2024 Financial Results
Total revenue of $12.2 million demonstrates the Company’s solid momentum year over year and ongoing growth in the rapidly expanding […]
